Company Name | Biocon |
---|---|
Website | https://www.biocon.com |
Snippet | Biocon is an innovation led fully integrated biopharmaceutical company that developes affordable biosimilars, novel biologics & complex APIs |
ISIN | INE376G01013 |
Type | Public |
Founded | 1978 |
Founder | Kiran Mazumdar-Shaw |
Revenue | ₹6,528.60 crore (US$920 million) [1] (2020) |
Website | www.biocon.com |
Industry | Biopharmaceutical |
Products | Biologics Small Molecules Branded Formulations Research Services |
Traded as | BSE: 532523 NSE: BIOCON |
Key people | Kiran Mazumdar-Shaw(Chairperson & MD)Siddharth mittal(CEO & Joint Managing Director) |
Net income | ₹748.20 crore (US$100 million) [1] (2020) |
Headquarters | Bangalore, Karnataka, India |
Subsidiaries | Syngene |
Total assets | ₹14,443.80 crore (US$2.0 billion) [2] (2020) |
Total equity | ₹6,705.80 crore (US$940 million) [2] (2020) |
Operating income | ₹1,214.90 crore (US$170 million) [1] (2020) |
Number of employees | 9,234 (Mar 2017)[3] |
Biocon is part of the India company list
Biocon is part of the Biotechnology company list
Have a list of company names and need to update information? Use our Company Search tool.
Please note that Powrbot Inc does not own this content and cannot vouch for its accuracy, we simply aggregate public information for ease of research.
Want to update this profile? Please contact us here with a link to the public source verifying the edit.
Powrbot Inc. is a passionate company working on problems using data analytics, automation & machine learning. Our goal is to automate the boring stuff.
Contact Us